Kyorin Pharmaceutical develops and markets prescription medicines. Its products include Beova for overactive bladder, Flutiform for asthma, Desalex for allergies, Lasvic antibacterial medicines and Pentasa for ulcerative colitis and Crohn's disease. About 600 medical representatives provide healthcare practitioners with information on appropriate use, focusing on respiratory, ear, nose and throat, and urology fields.
Drug discovery combines the company's small-molecule research with external technologies and partnerships. In March 2025 it licensed its in-house compound KRP-M223 to Novartis for global development. The group also develops and manufactures generic drugs through its subsidiary KYORIN Rimedio.
0
open positions at Kyorin Pharmaceutical
No live listings from Kyorin Pharmaceutical right now — browse all Tokyo software jobs instead.